ZAMO', Alberto
 Distribuzione geografica
Continente #
NA - Nord America 9.387
EU - Europa 7.495
AS - Asia 5.271
SA - Sud America 620
AF - Africa 140
Continente sconosciuto - Info sul continente non disponibili 134
OC - Oceania 19
AN - Antartide 1
Totale 23.067
Nazione #
US - Stati Uniti d'America 9.200
RU - Federazione Russa 2.557
SG - Singapore 2.117
GB - Regno Unito 1.702
CN - Cina 1.682
IT - Italia 744
BR - Brasile 472
DE - Germania 460
FR - Francia 459
SE - Svezia 456
VN - Vietnam 450
FI - Finlandia 393
HK - Hong Kong 377
IE - Irlanda 281
KR - Corea 165
UA - Ucraina 145
CA - Canada 123
IN - India 77
BD - Bangladesh 75
TR - Turchia 65
BE - Belgio 62
AR - Argentina 60
JP - Giappone 58
NG - Nigeria 57
NL - Olanda 49
ES - Italia 39
PL - Polonia 35
ID - Indonesia 34
ZA - Sudafrica 32
MX - Messico 30
IQ - Iraq 24
EC - Ecuador 21
IR - Iran 20
PK - Pakistan 19
LT - Lituania 18
AU - Australia 17
CL - Cile 17
AT - Austria 16
CO - Colombia 15
VE - Venezuela 15
RO - Romania 12
IL - Israele 11
NP - Nepal 11
PH - Filippine 10
UZ - Uzbekistan 10
CH - Svizzera 9
MY - Malesia 9
AZ - Azerbaigian 8
EG - Egitto 8
JM - Giamaica 8
JO - Giordania 8
KE - Kenya 8
CZ - Repubblica Ceca 7
DZ - Algeria 7
AL - Albania 6
CR - Costa Rica 6
MA - Marocco 6
BG - Bulgaria 5
HR - Croazia 5
KZ - Kazakistan 5
PE - Perù 5
PY - Paraguay 5
SA - Arabia Saudita 5
UY - Uruguay 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CI - Costa d'Avorio 4
EE - Estonia 4
ET - Etiopia 4
LV - Lettonia 4
NI - Nicaragua 4
RS - Serbia 4
EU - Europa 3
GR - Grecia 3
GT - Guatemala 3
HU - Ungheria 3
KG - Kirghizistan 3
LB - Libano 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
SI - Slovenia 3
SV - El Salvador 3
TH - Thailandia 3
TN - Tunisia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BY - Bielorussia 2
CY - Cipro 2
GE - Georgia 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
Totale 22.918
Città #
Southend 1.480
Singapore 1.174
Jacksonville 995
Ashburn 971
Moscow 867
Chandler 824
Dallas 757
San Jose 724
Woodbridge 524
Ann Arbor 466
Hong Kong 368
Beijing 305
Council Bluffs 285
Dublin 281
Houston 276
Verona 244
The Dalles 187
Wilmington 158
New York 157
Ho Chi Minh City 148
Los Angeles 148
Princeton 144
Lawrence 143
Jinan 121
Nanjing 119
Hanoi 104
Shenyang 91
Munich 90
Helsinki 89
Tianjin 72
Buffalo 71
Hebei 70
Sindelfingen 67
Brussels 60
Santa Clara 59
Boardman 56
Ningbo 56
Nanchang 54
Columbus 53
Abuja 51
São Paulo 50
Tokyo 50
Turku 50
Orem 47
Milan 46
Chicago 41
Haikou 41
Montreal 41
Zhengzhou 40
Changsha 36
Hangzhou 34
Taizhou 34
Guangzhou 33
Jiaxing 33
Phoenix 33
Redondo Beach 33
Dearborn 32
Frankfurt am Main 30
Bologna 28
Rome 28
San Francisco 28
Taiyuan 27
Warsaw 27
Denver 26
Toronto 26
Atlanta 24
Fairfield 24
Stockholm 24
Norwalk 23
Lancaster 22
London 22
Seoul 22
Johannesburg 21
Redmond 21
Brooklyn 20
Chennai 20
Groningen 20
Providence 20
Haiphong 19
Falls Church 18
Las Vegas 18
Falkenstein 17
Madrid 17
Paris 17
Amsterdam 16
Seattle 16
Fuzhou 15
Jakarta 15
Rio de Janeiro 15
Washington 15
Boston 14
Brasília 14
Mexico City 14
Da Nang 13
Redwood City 13
Curitiba 12
Manchester 12
Catania 11
Dongguan 11
Düsseldorf 11
Totale 14.409
Nome #
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 341
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 324
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 274
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 270
Chromium-induced diffuse dermatitis with lymph node involvement resulting from Langerhans cell histiocytosis after metal-on-metal hip resurfacing 249
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 247
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 244
slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP 243
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 242
Detection of allele-specific gene expression on next generation sequencing data 240
Application of a commercial software to the analysis of infrared structural images on lymph node tissues: a preliminary study 239
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 239
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 239
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 237
Analysis of colorectal cancers for human cytomegalovirus presence 236
[Primary large B cell non-Hodgkin's lymphoma of the mediastinum] 234
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. 232
Espressione di TP73L nei linfomi B a grandi cellule primitivi del mediastino: un utile marcatore diagnostico 231
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 231
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis 229
CD10 is expressed in a subset of chromophobe renal cell carcinomas 228
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 221
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 220
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 218
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 218
Espressione di marcatori di migrazione e invasività nei foci fibroblastici nella fibrosi polmonare idiopatica 217
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis 215
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 213
A Rare Disorder in an Orphan Disease: Kikuchi Fujimoto Disease in a Young-Adult Patient with Sickle Cell Anemia 207
Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy 206
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 201
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 201
Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure 201
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 200
FPA micro spectral imaging of non-Hodgkin lymphomas 198
Microfluidic Deletion/Insertion Analysis for Rapid Screening of KIT and PDGFRA Mutations in CD117-Positive Gastrointestinal Stromal Tumors: Diagnostic Applications and Report of a New KIT Mutation. 198
Application of Microfluidic Technology to the BIOMED-2 Protocol for Detection of B-Cell Clonality 193
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 192
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 191
A 6-GENE EXPRESSION SIGNATURE IN MANTLE CELL LYMPHOMA: RESULTS FROM THE FONDAZIONE ITALIANA LINFOMI (FIL)-MCL-0208 TRIAL 190
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 189
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 184
Establishment of the MAVER -1 cell line, a model for leukemic and aggressive mantle cell lymphoma. 184
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 182
Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol: a proteomic analysis. 181
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 181
Utilizzo di un apparato microfluidico per il rilevamento del riarrangiamento clonale dei geni delleimmunoglobuline secondo il protocollo BIOMED-2 180
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 179
Use of a Chip-based microfluidic apparatus in the analytic step of the Biomed-2 protocol for the detection of B-cell clonality 178
ALK-mediated activation of STAT3 elicits growth and anti-apoptotic signals. 178
Activated KIT hyperexpression in thymic carcinoma: a potential target for therapeutic intervention. 178
Identification of the core phosphoproteome of mantle cell lymphoma cell lines 178
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 177
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 176
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 175
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 174
ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors 173
In Vitro and In Vivo Model of EBV-Positive Non-Hodgkin Plasmablastic Lymphoma with Focal Plasmacytic Differentiation 173
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours 171
Application of a commercial software to the analysis of infrared spectral images on lymph node tissues: a preliminary study. 170
An unusual case of sarcoidosis in an adult patient with sickle cell disease: Management with methotrexate and low dose of steroid 170
Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study. 170
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 165
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 165
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 165
Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment 165
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death 163
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 163
PHOSPHOSCAN ANALYSIS OF MANTLE CELL LYMPHOMA CELL LINES 162
Tissue proteomics of splenic marginal zone lymphoma 162
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. 162
Utilizzo dell'analisi microfluidica per il rilevamento di mutazioni dei geni KIT e PDGFRA nei tumori dello stroma gastroenterico. 160
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 157
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 156
CD16 expression in T-cell lymphomas: analysis on paraffin embedded tissues using the 2H7 antibody. 152
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 152
Anaplastic lymphoma kinase in human cancer 151
VR09 Cell Line: An EBV-Positive Lymphoblastoid Cell Line with In Vivo Characteristics of Diffuse Large B Cell Lymphoma of Activated B-Cell Type 151
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 151
Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer. 147
Resveratrol activity on MCL cell line jeko-1: a proteomic approach 146
Anaplastic large-cell lymphoma 146
MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma 142
Precise sequance analysis of rearranged immunoglobulin genes in mantle cell lymphoma cell lines 141
The mantle cell lymphoma website: a free web-based resource for mantle cell lymphoma researchers 140
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 138
Metodi e tecniche dell'anatomia patologica 137
Models for quantitative individual grading and prognosis in breast malignancies 136
Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol : a proteomic analysis 136
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas 135
VDJSeq-Solver: In Silico V(D)J Recombination Detection Tool 135
Phosphoproteome profiling of mantle cell lymphoma cell lines 134
The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion 134
Impacts: planning a European initiative for standardized protein analysis of archival clinical tissues 133
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas 132
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 130
Genome-Wide Promoter Methylation Profiling Of Splenic Marginal Zone Lymphoma (SMZL) Identifies Two Subgroups Of Patients With Distinct Genetic and Biologic Features and Different Outcomes 129
Identification of a three-gene model as a powerful diagnostic tool for the recognition of ALK negative ALCL 128
Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole exome sequencing 128
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma 124
Totale 18.603
Categoria #
all - tutte 75.431
article - articoli 41.748
book - libri 0
conference - conferenze 32.453
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.230
Totale 150.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022696 0 0 0 96 44 28 13 76 47 41 105 246
2022/20232.380 174 241 248 438 223 523 16 141 275 20 53 28
2023/20241.095 59 102 78 145 132 178 42 74 15 48 146 76
2024/20252.799 135 230 87 474 122 78 132 89 468 172 251 561
2025/20268.291 590 489 672 1.329 2.024 584 718 409 634 494 149 199
2026/20271.172 95 235 470 372 0 0 0 0 0 0 0 0
Totale 23.067